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ABSTRACT  38 
Diets rich in fruit and vegetables are associated with a decreased incidence of colorectal cancer 39 
(CRC) due, in part, to the bioactive (poly)phenolic components and their microbiota-mediated 40 
metabolites. This study investigated how such compounds, derived from ingested raspberries in 41 
the gastrointestinal tract, may exert protective effects by reducing DNA damage. Ileal fluids 42 
collected pre- and post-consumption of 300 g of raspberries by ileostomists (n = 11) were 43 
subjected to 24 h ex vivo fermentation with fecal inoculum to simulate interaction with colonic 44 
microbiota. The impact of fermentation on (poly)phenolics in ileal fluid was determined and the 45 
bioactivity of ileal fluids pre- and post fermentation investigated. (Poly)phenolic compounds 46 
including sanguiin H-6, sanguiin H-10 and cyanidin-3-O-sophoroside decreased significantly 47 
during fermentation while, in contrast, microbial catabolites, including 3-(3′-48 
hydroxyphenyl)propanoic acid, 3-hydroxybenzoic acid  and benzoic acid increased significantly.  49 
The post-raspberry ileal fermentate from 9 of the 11 ileostomates significantly decreased DNA 50 
damage (~30 %) in the CCD 841 CoN normal cell line using an oxidative challenge COMET 51 
assay. The raspberry ileal fermentates also modulated gene expression of the nuclear factor 2–52 
antioxidant responsive element (Nrf2-ARE) pathway involved in oxidative stress 53 
cytoprotection, namely Nrf2, NAD(P)H dehydrogenase, quinone-1 and heme oxygenase-1. Four 54 
of the phenolic catabolites were assessed individually, each significantly reducing DNA damage 55 
from an oxidative challenge over a physiologically relevant 10-100 µM range.  They also induced 56 
a differential pattern of expression of key genes in the Nrf2-ARE pathway in CCD841 CoN cells. 57 
The study indicates that the colon-available raspberry (poly)phenols and their microbial-58 









1. Introduction  61 
(Poly)phenols contribute to chronic disease risk-reduction associated with diets rich in 62 
fruit and vegetables [1,2] through their pleiotropic bioactivity including anti-inflammatory, anti-63 
proliferative and anti-genotoxic activities [3−5]. The bioavailability of many (poly)phenol 64 
classes has traditionally been deemed low [6], but if the contribution of their gut microbiota-65 
mediated catabolites is considered, there is a growing realisation it is much greater than 66 
classically reported [7−11].   67 
The putative health benefits of dietary (poly)phenols probably occur via interactions within 68 
the gastrointestinal (GI) tract, including the production of bioactive microbiota-derived 69 
catabolites [10−13], maintenance of a beneficial microbiota population, and protection against 70 
epithelial damage associated with GI disease [14,15]. Consequently, numerous studies have 71 
emulated effects on the GI tract using a variety of in vitro models [16] including INFOGEST 72 
which advocates a standardised model including buccal simulation [17]. These models 73 
demonstrate that (poly)phenols have different stabilities and are likely available in amounts 74 
that could modulate physiological processes. They compare potential in-gut availability but 75 
cannot comprehensively mimic the dynamic and active processes associated with the digestion 76 
of food when consumed by humans [18]. However, ileostomy-based bioavailability studies 77 
provide a unique insight into events taking place in the GI tract, facilitating identification of 78 
compounds which, in individuals with an intact colon, would pass from the small to the large 79 
intestine and ultimately exert their effects [19−25].  80 
While numerous studies have reported bioactivities for (poly)phenols, especially anti-81 
genotoxicity effects, many are of limited physiological relevance as they largely ignored the 82 
importance of the digestive process on the composition, structure and bioactivity of the 83 
compounds in the GI tract [26−31]. Mechanistically, Nuclear factor erythroid 2-related factor 2 84 








(poly)phenols [32]. Moreover, Nrf2 is a target for the prevention of carcinogenesis [33,34] as it 86 
regulates the expression of a range of intracellular endogenous antioxidant and phase II 87 
detoxifying enzymes including; NAD(P)H:quinone oxidoreductase 1 (NQO1), heme oxygenase 1 88 
(HO-1), thereby providing cytoprotection. This function is exemplified by the Nrf2 knockout 89 
mouse model (Nrf2KO:  APCmin/+ x Nrf2-/-) which exhibits a reduced response to oxidative stress 90 
and enhanced tumorigenesis [35].  91 
In the current study an ex vivo approach coupling in vivo digestion by ileostomates to ex 92 
vivo fecal fermentation was used to produce physiologically relevant samples to explore 93 
whether (poly)phenols derived from consumption of raspberries could beneficially impact gut 94 
health, in terms of reduction of DNA damage and Nrf2-ARE pathway modulation. 95 
 96 
2. Methods  97 
2.1.  Chemicals and reagents  98 
Minimum essential media, penicillin/streptomycin, sodium pyruvate, non-essential amino 99 
acid, and foetal bovine serum were purchased from Gibco Life Technologies Ltd (Paisley, 100 
Scotland, UK). HPLC-MS grade methanol and acetonitrile were acquired from Panreac 101 
(Barcelona, Spain) and formic acid (HPLC-MS grade) from Sigma-Aldrich (Madrid, Spain). 102 
Cyanidin-3-O-glucoside and pelargonidin-3-O-glucoside were obtained from Apin Chemicals 103 
(Abingdon, Oxford, U.K.), cyanidin-3-O-sambubioside-5-O-glucoside was supplied by 104 
(Poly)phenols (Sandnes, Norway), and punicalagin was obtained from Chromadex (U.S.A). All 105 
other chemicals were purchased from Sigma-Aldrich (Poole, Dorset, UK). 106 
Note, the names for phenolic catabolites used in this paper is based on the nomenclature 107 










2.2.  Ileostomy feeding study  111 
The ileal fluid samples were obtained from an earlier raspberry feeding study [23] 112 
approved by the Ethics Committee at the University of Ulster (Ref No. 11/NI/0112) and carried 113 
out in accordance with The Code of Ethics of the World Medical Association (Declaration of 114 
Helsinki) for experiments involving humans.  Briefly, after a 48 h diet low in (poly)phenols and 115 
an overnight fast, 11 healthy ileostomy volunteers provided a baseline ileal fluid sample. They 116 
then consumed 300 g of  homogenised raspberries and a second ileal fluid sample was collected 117 
8 h post-consumption. Samples were processed as described previously [23], and stored at −80 118 
°C.  119 
 120 
2.3.   Ex vivo fermentation of ileal fluid 121 
To simulate the colonic environment ileal fluid samples were fermented with a human 122 
fecal inoculum for 24 h in a pH, temperature-controlled in vitro batch culture model. In brief, 123 
sterile water-jacket vessels were filled aseptically with 85 mL of basal nutrient media. The 124 
vessels were equipped with a continuous oxygen-free nitrogen supply and an automated pH-125 
regulation system connected with NaCl (0.5 M) and HCl (0.5 M) reservoirs. A single fecal donor, 126 
fulfilling the pre-requisites described previously [37], provided verbal consent for the fecal 127 
matter to be used for the experiments in compliance with the ethics procedures of the 128 
University of Reading. A single donor was used to minimise variation as a result of metabotype 129 
[38]. Once weekly, for 4 weeks, the donor provided a stool sample, which was collected and 130 
within an hour homogenised via a stomacher (Seward, Norfolk, UK) and diluted 1:10 using 131 
sterile pre-reduced phosphate-buffered saline (PBS). A 15 mL fecal slurry and 50 mL of either 132 
baseline or raspberry ileal fluid were added to the fermentation vessel. The following conditions 133 








constant stirring, pH ~6.6. Aliquots of fermentates were collected before (0 h) and after (24 h) 135 
fecal fermentation, centrifuged at 13,500 rpm at 4 °C for 5 min and the supernatant filtered 136 
through 0.22 µm filters before being aliquoted and stored at −80 °C. 137 
 138 
2.4.  UHPLC-HR-MS analysis of (poly)phenols in ileal fluids and fermented samples   139 
Extraction of (poly)phenolic compounds from ileal fluid and fermentates used a previously 140 
described method [23] and were analysed using a Dionex Ultimate 3000 RS UHPLC system 141 
comprising of a UHPLC pump, a PDA detector scanning from 200 to 600 nm and an autosampler 142 
operating at 4 °C (Thermo Scientific, San Jose, CA, USA). Separation of anthocyanins, 143 
ellagitannins and ellagic acids were derivatives was carried out using a 100 x 2.1 mm i.d. 1.8 µm 144 
Zorbax SB C18 column (Agilent Technologies, Berkshire, U.K.) maintained at 40 °C and eluted at 145 
a flow rate of 0.2 mL/min with a 50 min gradient of 3-70 % 0.1 % acidic methanol in 0.1 % 146 
aqueous formic acid. After passing through the flow cell of the PDA detector the eluate was 147 
directed to an ExactiveTM Orbitrap mass spectrometer fitted with a heated electrospray 148 
ionization probe (Thermo Scientific) operating in either negative ionization mode for the 149 
analysis of ellagitannins and gallic acids or in positive ionization mode for the anthocyanins. In 150 
negative ionization mode, analyses were based on scanning from 100 to 1000 m/z, with in-151 
source collision-induced dissociation at 25.0 eV. The capillary temperature was 350 °C, the 152 
heater temperature was 150 °C, the sheath gas and the auxiliary gas flow rate were set at 25 and 153 
5 units, respectively, and the sweep gas was 4 and the spray voltage was 3.00 kV. In positive 154 
ionization mode, analyses were based on scanning from 100 to 1000 m/z, with in-source 155 
collision-induced dissociation at 20.0 eV. The capillary temperature was 300 °C, the heater 156 
temperature was 150 °C, the sheath gas and the auxiliary gas flow rate were 40 and 10 units, 157 
respectively, and the sweep gas was 4 and the spray voltage was 3.00 kV. Data acquisition and 158 








Identification was achieved by comparing the exact mass and the retention time with 160 
available standards, or by comparison with theoretical exact mass of the molecular ion with the 161 
measured accurate mass of the molecular ion, when standards were unavailable  (see Table S1 162 
in the Supplementary Information). Anthocyanins were quantified based on the theoretical 163 
exact mass of the molecular ion by reference to 0.05–100 ng/µL standard curves of cyanidin-3-164 
O-glucoside and pelargonidin-3-O-glucoside. Ellagitannin and ellagic acid quantifications were 165 
carried out selecting the theoretical exact mass of the molecular ion by reference to 0.01-100 166 
ng/µL standard curves of a mix of punicalagin and ellagic acid. A linear response was obtained 167 
for all the standard curves, as checked by linear regression analysis (R2 > 0.999). Limits of 168 
detection (ranging from 0.1 to 0.5 ng), limits of quantification (0.3-1.8 ng) and precision of the 169 
assay (as the coefficient of intra-assay variation, ranging from 1.5 to 4.7 %) were considered 170 
acceptable, allowing the quantification of (poly)phenol compounds. 171 
 172 
2.5.  GC-MS Analysis of phenolic acid catabolites in fermented samples  173 
Extraction of phenolic compounds from ileal fluid and fermentates was performed using 174 
procedures described by Pereira-Caro et al. [8]. The phenolic catabolites from purified samples 175 
were analysed on a 6890 gas chromatograph equipped with a 7683S autosampler, a 5973 mass 176 
spectrometer (Agilent Technologies) and a ZB-5MS Zebron 30 m x 0.25 mm x 0.25 µm (i.d.) 177 
capillary column (Phenomenex, Macclesfield, Cheshire, U.K.) with helium as a carrier gas (1.2 178 
mL/min). The GC-MS conditions were: injection volume (1 µL), split ratio (1:25), initial 179 
temperature 40 °C raised to 160 °C at 20 °C/min, to 200 °C at 1.5 °C/min, to 250 °C at 10 °C/min 180 
and a final temperature of 300 °C at 40 °C/min, which was held for 5 min. Injector, MS transfer 181 
line and ion source were maintained at 22 °C, 150 °C, and 230 °C, respectively. Mass spectra 182 
were scanned at m/z 50-470 and ionization energy of 70 eV. Phenolic compounds were 183 








was based on calibration curves of the ratio between the m/z of the target ion of the standard of 185 
interest and the target ion of the 2′,4′,5′-trimethoxycinnamic acid internal standard. For further 186 
information on the analytical method see Table S2. 187 
 188 
2.6.  Biological activity assays 189 
2.6.1.  Tissue culture 190 
Normal human epithelial colon cells, (CCD 841 CoN) [39] acquired from the American 191 
Type Culture Collection were incubated at 37 °C with 5 % CO2 and grown as monolayers in roux 192 
flasks. Cells were sub-cultured every 3–4 days by the addition of trypsin (0.25 % trypsin-EDTA) 193 
at 37 °C for 5 min. Cells were centrifuged at 1,200 rpm for 3 min, the supernatant decanted, and 194 
cells resuspended in growth media. Cells were exposed to either ileal fluid fermentates or one of 195 
four phenolic acids, namely 3-(3′-hydroxyphenyl)propanoic acid, 3-(phenyl)propanoic acid, 4-196 
hydroxybenzoic acid, and benzoic acid at 10, 50, and 100 µM.  A 5 mM stock solution for each 197 
phenolic was prepared in 0.5 % DMSO in PBS and subsequently diluted to test range in growth 198 
media to 0.01 % DMSO. 199 
Exposure to treatments. Cell viability was assessed via the MTT assay [40]. Due to the 200 
limited volume of ileal fluid fermentates available, a sample from a single participant was 201 
assessed at up to 40 % v/v which establish a sub-cytotoxic dose of 20 %.  Cell viability was also 202 
established for the phenolic acids at 10, 50, and 100 µM.  203 
For all experiments CCD 841 CoN cells were incubated with ileal fluids (20 % v/v media) 204 
or phenolic acids at 10, 50, or 100 µM. An exposure time of 24 h was selected for all ex vivo 205 
studies, as it is generally considered to reflect the average colonic transit time.   206 








The COMET assay was conducted to determine the effect on DNA damage on normal 208 
epithelial colonic cells by 0 h and 24 h fermented ileal fluids at 20 % (v/v in media) and by 209 
phenolic acids at 10, 50, or 100 µM, as outlined by De Santiago et al. [40]. Briefly, CCD 841 CoN 210 
cells were incubated with the various treatments for 24 h, prior to an oxidative challenge with 211 
25 µM hydrogen peroxide or PBS. Results were acquired and analysed using Nikon eclipse 600 212 
epifluorescent microscope and Komet 5.0 software (Kinetic Image ltd, Liverpool, UK). A total of 213 
50 cells per gel were scored with a mean % tail DNA calculated from triplicate gels; each 214 
experiment was repeated three times, independently. 215 
 216 
2.7.  RNA isolation and cDNA synthesis 217 
Following the method of McDougall et al. [41], after incubation for 24 h with one of the 218 
various treatments 841 CoN cells were collected, centrifuged, and the cell pellet homogenized 219 
using QIAshredder (Qiagen, UK). RNA was extracted with RNeasy Mini Plus Kit (Qiagen, UK) and 220 
its quality determined. The anchored-oligo(dT)18 and Transcriptor First Strand cDNA synthesis 221 
Kit (Roche) were used to obtain 20 µL of cDNA from 1 µg of RNA and its specificity based on the 222 
hypoxanthine phosphoribosyl transferase (HPRT) gene was determined via Lightcycler 480II 223 
(Roche). Following positive result, the cDNAs were stored at −20 °C. 224 
 225 
2.8.  Real-time PCR (qPCR) 226 
An adapted version of the method of McDougall et al. [41] was used for primers design, 227 
qPCR performance and results analysis. In brief, OligoPerfect (Thermo Fisher, UK) and NCBi 228 
Primer-BLAST (USA) were used to design the primers for three genes belonging to the Nrf2-ARE 229 
pathway; Nuclear factor erythroid 2-related factor 2 (Nrf2), Heme oxygenase 1 (HO-1), and 230 








Table S3. The expression of each target cDNA sample was normalized using two housekeeping 232 
genes (HPRT and β-actin) and calculated as a ratio of the untreated control samples. All target 233 
cDNA samples were run as technical triplicates.  234 
 235 
2.9.  Statistical analysis 236 
The mean of three independent experiments ± standard deviation (SDM) was calculated 237 
for each type of dataset and used for the statistical analysis. The Shapiro-Wilk test was used to 238 
determine normality. Paired-samples t-test, for COMET ileal fluid results, and One-way ANOVA 239 
and Dunnett’s Multiple comparison post-hoc test, for results from phenolic compounds and 240 
gene expression studies, were used to assess significant differences between means 241 
(significance levels p<0.05). Analyses were performed using IBM SPSS Statistics for Windows 242 
(version 25.0, 2017. Armonk, NY: IBM Corp). 243 
Analyses of (poly)phenol content were performed in triplicate. Data are reported as mean 244 
values ± standard error (SEM). One-way ANOVA was performed to evaluate significant 245 
differences between metabolites presented before and after fermentation (significance levels 246 
p<0.05). The statistical analysis was performed using R software (version 3.5.0). 247 
Multivariate statistical analysis (Multilevel PLS-DA, Partial Least Square Discriminant 248 
Analysis), where the between subject variation is separated from the within subject variation, 249 
was used for selection of the most discriminative metabolites between groups. Models were 250 
optimized based on a leave-one out cross validation. Variable Importance in Projection (VIP) 251 
scores were obtained and only metabolites that exceeded an initial threshold, set to 0.9, were 252 
selected. All these analyses were carried out using R software (version 3.5.0) and the Solo 253 









3.   Results 256 
3.1.    Characterization of the ileal fluids before and after fecal fermentation 257 
The (poly)phenolic composition of the ingested 300 g of raspberries has been described 258 
previously (see Table S4), as have the levels recovered in ileal fluid collected 0-8 h after 259 
raspberry consumption [41]. In the current study these ileal fluid samples from 11 subjects 260 
were subjected to ex vivo fecal fermentation, with samples taken pre- (0 h) and post-261 
fermentation (24 h) being analysed by UHPLC-HRMS and GC-MS. The changes in the amounts of 262 
key anthocyanins, ellagic acid derivatives and ellagitannins following fermentation are 263 
presented in Table 1. Substantial inter-individual variation was evident in the (poly)phenolic 264 
composition of the raspberry ileal fluid before fermentation (0 h). The amounts of the major 265 
ellagitannins varied considerably with sanguiin H-6 levels of 0.6 - 35.1 µmol and sanguiin H-10 266 
of between 1.0 - 10.0 µmol. The most abundant anthocyanin, cyanidin-3-O-sophoroside ranged 267 
from 0.6 to 10.0 µmol and the least abundant anthocyanins, cyanidin-3-O-glucoside (n.d. - 0.3 268 
µmol) and pelargonidin-3-O-sophoroside (n.d. - 0.1 µmol) also showed inter-individual 269 
variation. However after 24 h fecal fermentation, the quantities in the raspberry ileal fluids 270 
decreased, with cyanidin-3-O-sophoroside at 0.2 - 4.0 µmol, sanguiin H-6 at 0.1 - 3.3 µmol, 271 
sanguiin H10 at 0.1 - 0.9 µmol, cyanidin-3-O-glucoside (n.d. - 0.1 µmol) and pelargonidin-3-O-272 
sophoroside (n.d. - 0.04 µmol). Ellagic acid was also reduced from 1.2 - 20.0 µmol to 1.1 - 11.1 273 
µmol, but the decreases (8.3 - 44.5%) were much less severe than those of the anthocyanins and 274 
ellagitannins. In context of the original quantity of raspberry (poly)phenols consumed, only 7% 275 
of the ingested dose of cyanidin-3-O-sophoroside was recovered at the end of the simulated 276 
colonic fermentation, less than 2% of ingested sanguiin H-6 and H-10 but  109% of ingested 277 
ellagic acid (Table 2). The increase in ellagic acid is due to its release from ellagitannins and 278 
ellagic acid glycosides in the ileum and continued degradation of these components by the fecal 279 








In contrast to the substantial decrease in the amounts of most (poly)phenols (Table 2), 281 
total phenolic acids and aromatic catabolites increased significantly (~30 %, p<0.005) in the 282 
raspberry ileal fluids after 24 h fermentation (Fig. 1). Details of the volunteer-volunteer 283 
variations are presented in Fig. 2.  A total of 17 phenolic acid catabolites were detected and 284 
quantified in the raspberry ileal fluid samples before and after fermentation (Table S5) 285 
including benzoic acid (4.7 - 132 µmol), 3-(3′-hydroxyphenyl)propanoic acid (n.d. - 8 µmol), 3-286 
(phenyl)propanoic acid (n.d. - 19 µmol), and, 4-hydroxybenzoic (n.d. - 26 µmol).  287 
Based on the data in Table S5 and the voided volumes of 0-8 h ileal fluid, it is noteworthy 288 
that the concentration, as opposed to the quantity of (poly)phenols in the eleven 0-h pre-289 
fermented raspberry ileal fluid samples ranged from 55 - 1668 µM (mean 581 ± 171 µM)  while 290 
the 24-h post-fermented samples contained 162 –1962 µM (mean 807 ± 187 µM)  (Table 3).  291 
Information on the concentration of the 17 individual phenolic acids is presented in Table S6.  292 
Although the fecal microbiota donor was constant across each of the gut models, high 293 
inter-person variation was evident in the concentrations of the catabolites detected. To 294 
overcome this variation and to obtain a clearer picture of the impact of fecal fermentation on 295 
the phenolic composition of ileal fluid(s) a multivariate approach (multilevel partial least 296 
squares-discriminant analysis, ML-PLS-DA) was carried out (Fig. 3). As shown in Fig. 3A there 297 
was a clear differentiation between the pre- and post-fermentation ileal fluid samples, with an 298 
average classification error of 0.00, which accounted for 27.3 % of total variance (latent variable 299 
1, LV1) (Fig. 3A). Eight phenolic acid catabolites were indicated as the key discriminators of the 300 
fermentation of the baseline ileal fluid samples (Fig. 2B) with significant increases in 3-(4´-301 
hydroxyphenyl)propanoic acid, 4-hydroxybenzoic acid and 3-(3´-hydroxyphenyl)propanoic 302 
acid. Fourteen key compounds were identified, with LV1 accounting for 48.7 % of total variance, 303 
which discriminated between the before and after fermentation states (Figs. 3C and 3D). 304 








decreased significantly during fermentation of raspberry ileal fluid, while low molecular weight 306 
phenolics including 3-(3´,4´-dihydroxyphenyl)propanoic acid, 3-(3′-hydroxyphenyl)propanoic 307 
acid, 4′-hydroxyphenylactic acid, 3-phenylacetic acid, 3,4-dihydroxybenzoic acid, 4-308 
hydroxybenzoic acid, benzoic acid,  and benzene-1,2,3-triol significantly increased. The 309 
microbial catabolites benzoic acid, 4-hydroxybenoic acid, and 3-(3′-hydroxyphenyl)propanoic 310 
acid were identified as discriminants of fermented raspberry ileal fluids (Fig. 3D) and, along 311 
with 3-(phenyl)propanoic acid, were used for subsequent bioactivity studies.   312 
 313 
3.2.   Bioactivity of ileal fluid fermentates and microbial metabolites 314 
3.2.1.   Ileal fluid fermentates 315 
 For the majority of participants, the fermented raspberry ileal fluids exerted a 316 
significantly greater reduction of DNA damage than the pre-fermented condition (Fig. 4A). At 0 317 
h, 6 out of the 11 raspberry ileal fluids (Fig. 4A; participants S2, S3, S5, S8, S10 and S11), 318 
significantly decreased % Tail DNA compared to their baseline counterparts. After a 24 h 319 
fermentation, 9 out of 11 raspberry ileal fluids (Fig. 3B; participants S1, S2, S3, S4, S5, S6, S8, 320 
S11 and S12), exerted significantly greater reduction of DNA damage than the baseline samples. 321 
Moreover, the ileal fluid fermentates themselves, without an oxidative challenge, exhibited little 322 
inherent DNA damaging activity (average 5.9 ± 2.7 % Tail DNA), while the average % Tail DNA 323 
for experimental controls (media only) after challenge with H2O2 or PBS, was 50.8 ± 3.5 and 4.1 324 
± 0.2 respectively.  325 
The Nuclear factor erythroid 2-related factor 2 (Nrf2) regulate genes encoding NAD(P)H 326 
dehydrogenase, quinone-1 (NQO1) and heme oxygenase-1 (HO-1), reduce reactive oxygen 327 
species and play a key role in cytoprotection. Raspberry ileal fluid samples generally increased 328 
target gene expression (, NQO1 and HO-1) while the baseline samples down-regulated these 329 








control) by 8 out of 11 baseline ileal fluids (participants S1, S2, S3, S4, S5, S6, S8 and S10). 331 
Expression of NQO1 was significantly down-regulated, at least 50 % (p<0.001), by all baseline 332 
ileal samples with the greatest decrease following incubation with S5 (2.27-fold, p<0.001). 333 
Significant reductions (p<0.01) in HO-1 expression ranging from 1.07-fold to 1.64-fold were 334 
observed after treatment with 7 out of 11 baseline samples (participants S1, S2, S8, S9, S10, S11 335 
and S12).   336 
On the other hand, the raspberry ileal fluids generally caused increases in expression of 337 
target genes, apart from samples for participant S10. For Nrf2, 10 of 11 raspberry samples 338 
caused increases in expression with 6 (participants S2, S3, S5, S6, S11 and S12) being significant 339 
(Fig. 5). For NQO1, 8 raspberry samples showed significant increases in expression 340 
(participants S1, S2, S3, S4, S5, S6, S11 and S12) while for HO-1, 8 samples showed significant 341 
increases in expression with sample S5 causing a 6.87-fold increase (p< 0.001). 342 
 343 
3.3.  Phenolic catabolites   344 
The microbial catabolites benzoic acid, 4-hydroxybenzoic acid, and 3-(3′-345 
hydroxyphenyl)propanoic acid were identified as discriminants of raspberry fermented ileal 346 
fluids (Fig. 3D).  These were assessed at a sub-cytotoxic dose range (data not shown) for DNA 347 
damage activity.  3-(Phenyl)propanoic acid  was also assessed as a non-hydroxylated 348 
comparator to 3-(3′-hydroxyphenyl)propanoic acid. Pre-treatment with all these phenolic acids 349 
at concentrations comparable with the those detected in some of the pre- and post-fermented 350 
ileal fluid (Table S5) decreased DNA damage induced by an oxidative challenge in a dose-351 
dependent manner. At 100 µM, they reduced DNA damage by ~50 % (p<0.001) compared to the 352 
untreated control (Fig. 6) whereas at the lowest concentration (10 µM) all but 3-353 








with these effects, the phenolic acids also induced upregulation of expression of Nrf2, NQO1 and 355 
HO-1 genes in a dose-dependent manner with up to a 3-fold increase in expression (Fig. 7).  356 
 357 
4.  Discussion 358 
The study of (poly)phenol rich foods on gut health has been hampered by the frequent testing 359 
of physiologically irrelevant compounds [26−31]. More recently, the importance of the colonic 360 
microbiota in the biotransformation and consequently the bioactivity of (poly)phenols has been 361 
appreciated [10−13] through evidence obtained predominantly through ex vivo fermentation 362 
models, using human fecal microbiomes to catabolise either whole foods, in vitro digested 363 
(poly)phenolic extracts [37,42] or individual phenolic compounds [38,43]. In the current study 364 
use was made of ileal fluid, which provides a source of dietary compounds not absorbed by the 365 
small intestine  that would ultimately become available for interaction with the gut microbiota 366 
and the colonic epithelium. The ileal fluid samples were subjected to ex-vivo fecal fermentation 367 
and analysed for changes in phytochemical composition, activity in protection against DNA 368 
damage and activation of the Nrf2-ARE pathway. 369 
The recovery of ingested anthocyanins in ileal fluids after raspberry intake (e.g. 370 
anthocyanins 6.3 ± 1.2 µmol, ~16.5 % of intake), was consistent with the recovery rates (11.7-371 
40 %) reported for other ileostomy bioavailability studies on berries [20,22,24].  A 24 h fecal 372 
fermentation of these samples, demonstrated significant catabolism of the raspberry 373 
(poly)phenols with a total mean recovery of only 5.4 % of anthocyanins and 1.4 % of 374 
ellagitannins compared with the amounts in  the 300 g of ingested raspberries (Table 2, Fig. 2). 375 
This ex vivo study demonstrated the residual raspberry anthocyanins in ileal fluids were heavily 376 
catabolized by fecal microbiota (1.8 - 20.7 µmol, Table 1) and thereby contributed to the 377 
significant increase in the total concentration of phenolic and aromatic compounds from 581 ± 378 








Indeed, anthocyanins that resist upper GI tract metabolism are deglycosylated and the 380 
released anthocyanidins subjected to fission of the C-ring, with the released A- and B-ring 381 
fragments converted to a broad range of microbial-derived phenolic acid and aromatic 382 
compounds [10,13]. For example, cyanidin is degraded in vitro by the colonic microbiota via B-383 
ring fission to 3,4-dihydroxybenzoic acid and subsequently to 4-hydroxybenzoic acid, or 384 
alternatively transformed, to a lesser extent, to 3-(3´,4´-dihydroxyphenyl)propanoic acid and 385 
then converted to phenylpropanoic and phenylacetic acid derivatives [45]. Therefore, 386 
accumulation of these microbially-derived compounds (Tables 3 and S5) is likely a consequence 387 
of the colonic degradation of the raspberry anthocyanidins. In contrast, urolithins are 388 
microbially-derived from ellagitannins and ellagic acids [20, 45], and these were absent in the 389 
raspberry ileal fluids. This is probabaly a consequence of the single fecal sample donor being a 390 
metabotype 0 lacking bacterial strains, such as Gordonibacter species, G. urolithnfaciens and G. 391 
pamelaeae, that are required for conversion of ellagitannins and ellagic acids to urolithins [46]. 392 
Comparing the ex vivo digestion model to commonly used in vitro digestions, key differences in 393 
either (poly)phenol composition and/or estimated concentration are found [47]. In vitro 394 
digestion procedures cannot fully mimic uptake through the action of the small intestine brush-395 
border enzymes phlorizin-hydrolase and cytosolic β-glucosidases [13] nor any hepato-portal 396 
efflux, and thereby overestimates recovery. For example, the total parent anthocyanin recovery 397 
after in vitro digestion of a raspberry extract has been reported between 40 and 60 % [47] 398 
rather than 16.5 % observed in ileal fluid (Table 2) in the current study.  399 
In the present study the ex-vivo approach offers an opportunity to evaluate (poly)phenol 400 
metabolites and catabolites in a physiologically relevant context, as all too often biological 401 
effects are assessed at supra-physiological concentrations (e.g. 20-40 µM of cyanidin-3-O-402 
glucoside [48] or 120 µM of cyanidin-3-O-rutinoside [28], which contrasts to their maximum 403 
respective concentrations of 0.3 µM and 0.1 µM  noted in the raspberry fermented ileal fluids 404 








(Poly)phenols exert chemopreventive effects, in part by inhibiting DNA damage via 406 
modulation of antioxidant response pathways [32], which is important given that an excess of 407 
oxidants are able to alter the normal structure and function of DNA, lipids, and proteins, leading 408 
to mutations or oxidative damage. Following the consumption of raspberries, ileal fluids were 409 
characterised by the presence of high quantities of microbially-derived phenolic metabolites 410 
(162 – 1962 µM, Table 3) rather than the parent (poly)phenolic compounds (~12 µM; Table 3). 411 
Nine out the eleven raspberry ileal fluid fermenates exerted significantly greater reduction in 412 
DNA damage (~29 %) than then their baseline counterparts (Fig. 4).  413 
The microbial metabolites benzoic acid, 4-hydroxybenzoic acid and 3-(3′-414 
hydroxyphenyl)propanoic acid were noted as being representative of the fermentation of the 415 
raspberry ileal fluids and were shown to have potency against DNA damage at concentrations 416 
observed within the fermentates (Table S5). Previously, 100 and 200 µM of benzoic acid was 417 
reported to be neuro-protective against oxidative challenges [49] while 50-1000 µM  5-O-418 
caffeoylquinic acid (aka chlorogenic acid) and its microbial metabolites, 3′,4′-419 
dihydroxycinnamic acid (aka caffeic acid), 3-(phenyl)propanoic acid and benzoic acid exerted 420 
anti-proliferative effects in Caco2 cells (50-1000 µM) and mixtures of these compounds 421 
increased potency [50].  422 
Despite the different spectrum of phenolic catabolites in the pre-and post-fermented 423 
raspberry ileal fluids, no simple correlations with either total or individual phenolics could be 424 
derived to explain the greater DNA damage reduction of the fermented samples (Fig. 4B). The 425 
ileal samples reflect consumption of a whole food and consequently contain a complex mixture 426 
of (poly)phenolic compounds, as well other potential bioactive components. It is, therefore, 427 









The cytoprotective effects noted are likely mediated through the Nrf2-ARE pathway and 430 
activation of downstream regulated target genes such as HO-1 or NQO1 either by affecting ROS 431 
or promotion of Nrf2 nucleus translocation by inhibition of ubiquitination Kelch-like ECH-432 
associating protein 1 [32]. The majority (9 out of 11) of raspberry ileal fluids significantly 433 
increased (>2-fold) the expression of Nrf2, HO-1 or NQO1 in CCD 841 CoN cells, as did the 434 
selected microbial catabolites (10-100 µM). Modulation of gene expression in the Nrf2-ARE 435 
pathway in colonocytes has been reported for cyanidin-3-O-glucoside, albeit at high, 20 - 40 µM, 436 
concentrations which also significantly increased HO-1 and NQO1 in Caco2 cells [48]. Raspberry 437 
triterpenoids at a much lower 100 nM dose upregulated NQO1 and down regulated Nrf2 and 438 
HO-1 while reducing DNA damage in CCD 841cells [41]. It is also noteworthy that anthocyanin-439 
rich bilberry extract (Vaccinium myrtillus L.) consumption in humans upregulated NQO1 but 440 
decreased Nrf2 and HO-1 gene expression in peripheral blood mononuclear cells concomitant 441 
with DNA damage reduction. However, these benefits were not apparent in subjects lacking a 442 
colon (ileostomates), highlighting the importance of colonic catabolism in causing systemic 443 
changes [51].  444 
 445 
5.  Conclusions 446 
Following consumption of raspberries, (poly)phenols that survive digestion in the small 447 
intestine enter the colon where they are subject to microbial catabolism. We have demonstrated 448 
that physiologically relevant raspberry-enriched ileal fluid fermentates reduce DNA damage in 449 
normal colonocytes mediated in part by the up-regulation of the cytoprotective Nrf2-ARE 450 
pathway driven by (poly)phenolic catabolites. Therefore, modifications of raspberry 451 
(poly)phenols in the GI tract result in the production of low molecular weight catabolites that 452 
may exert protective effects against colonic epithelial damage in vivo by reducing DNA damage, 453 
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Table 1. Quantities of (poly)phenols in ileal fluid from subjects who consumed 300 g of raspberries before (0 h) and after (24 h) fecal fermentation. Data 
expressed as µmol ± SDM (n=3)1. 
Phenolic compounds S1-0 h S1-24 h S2-0 h S2-24 h S4-0 h S4-24 h S5-0 h S5-24 h S6-h S6-24 h 
Cyanidin-3-O-sophoroside 6.4 ± 0.5a 1.8 ± 0.2b 3.3 ± 0.3a 1.1 ± 0.1b 5.2 ± 0.6a 1.9 ± 0.2b 0.6 ± 0.1 a 0.2 ± 0.1b 5.0 ± 1.2a 1.6 ± 0.4b 
Cyanidin-3-O-(2"-O-
glucosyl)rutinoside 
1.3 ± 0.4a 0.5 ± 0.1b 1.2 ± 0.1a 0.4 ± 0.0b 1.3 ± 0.2a 0.4 ± 0.1b 0.2 ± 0.1a 0.1 ± 0.0b 1.2 ± 0.3a 0.4 ± 0.1b 
Pelargonidin-3-O-sophoroside 0.1 ± 0.0a 0.03 ± 0.02b 0.1 ± 0.0a 0.02 ± 0.00b 0.1 ± 0.0a 0.02 ± 0.00b n.d. n.d. 0.1 ± 0.0a 0.02 ± 0.01b 
Cyanidin-3-O-glucoside 0.06 ± 0.04a 0.02 ± 0.01b 0.3 ± 0.0a 0.1 ± 0.0b 0.1 ± 0.0a 0.03 ± 0.01b n.d. n.d. 0.1 ± 0.0a 0.02 ±0.00b 
Cyanidin-3-O-rutinoside 0.2 ± 0.0a 0.1 ± 0.0b 0.1 ± 0.0a 0.03 ± 0.00b n.d. n.d. 0.1 ± 0.1a 0.1 ± 0.0a 0.2 ± 0.0a 0.1 ± 0.0b 
Total anthocyanins 8.1 ± 0.9a 2.4 ± 0.3b 5.0 ± 0.4a 1.6 ± 0.1b 6.7 ± 0.8a 2.3 ± 0.3b 0.9 ± 0.3a 0.4 ± 0.1b 6.6 ± 1.5a 2.1 ± 0.5a 
Ellagic acid pentoside 0.2 ± 0.1a 0.04 ± 0.02b 0.5 ± 0.1a 0.1 ± 0.0b 0.4 ± 0.2a 0.1 ± 0.1b 0.1 ± 0.1a 0.1 ± 0.0b 0.4 ± 0.2a 0.1 ± 0.1a 
Ellagic acid    3.8 ± 0.5a 3.6 ± 0.4a 6.2 ± 2.3a 4.8 ± 2.1a 9.5 ± 4.8a 8.0 ± 4.0a 1.2 ± 0.1a 1.1 ± 0.1a 9.5 ± 2.3a 6.2 ± 1.6b 
Total ellagic acid 4.0 ± 0.6a 3.64 ± 0.42a 6.7 ± 2.4a 4.9 ± 2.1a 9.9 ± 5.0a 8.1 ± 4.1a 1.3± 0.2a 1.2 ± 0.1a 9.9 ± 2.5a 6.3 ± 1.7b 
Sanguiin H-10 9.4 ± 0.5a 0.9 ± 0.0b 4.7 ± 0.6a 0.5 ± 0.1b 5.2 ± 0.2a 0.3 ± 0.0b 1.0 ± 0.1a 0.1 ± 0.0b 6.4 ± 1.4 0.5 ± 0.1b 
Sanguiin H-6 4.7 ± 0.7a 0.5 ± 0.1b 7.5 ± 3.2a 0.7 ± 0.3b 23.0 ± 2.5a 2.0 ± 0.2b 0.6 ± 0.1a 0.1 ± 0.0b 15.0 ± 2.3a 1.3 ± 0.2b 
Lambertianin C n.d. n.d. 0.5 ± 0.6a 0.1 ± 0.1b 3.3 ± 1.6a 0.2 ± 0.1b n.d. n.d. n.d. n.d. 
Total ellagitannins 14.1 ± 1.1a 1.4±0.1b 12.7 ± 4.4a 1.3 ± 0.5b 31.5 ± 4.3a 2.5 ± 0.3b 1.6 ± 0.2a 0.2 ± 0.0b 21.4 ± 3.7a 1.8 ± 0.3b 
Total (poly)phenols 26.2 ± 2.6a 7.4±0.8b 24.4 ± 7.2a 7.8 ± 2.7b 48.1 ± 10.1a 12.9 ± 4.7b 3.8 ± 0.7a 1.8 ± 0.2b 37.9 ± 7.7a 10.2 ± 2.5b 
           
(Poly)phenolic compounds S9-0 h S9-24 h S10-0 h S10-24 h S11-0 h S11-24 h S12-0 h S12-24 h 
Cyanidin-3-O-sophoroside 10.0 ± 0.3a 4.0 ± 0.1b 5.1 ± 0.5a 1.8 ± 0.1b 2.9 ± 0.6a 1.0 ± 0.2b 1.5 ± 0.6a 0.5 ± 0.2b 
Cyanidin-3-O-(2"-O-
glucosyl)rutinoside 
2.4 ± 0.0a 0.8 ± 0.0b 1.2 ± 0.0a 0.4 ± 0.0b 0.7 ± 0.3a 0.2 ± 0.1b 0.4 ± 0.1a 0.2 ± 0.1b 
Pelargonidin-3-O-sophoroside 0.1 ± 0.0a 0.04 ± 0.00b 0.1 ± 0.0a 0.02 ± 0.00b 0.1 ± 0.0a 0.01 ± 0.00b n.d. n.d. 
Cyanidin-3-O-glucoside 0.1 ± 0.0a 0.03 ± 0.00b 0.1 ± 0.0a 0.02 ± 0.00b 0.1 ± 0.1a 0.1 ± 0.1b 0.1 ± 0.0a 0.01 ± 0.01b 
Cyanidin-3-O-rutinoside 0.2 ± 0.03a 0.1 ± 0.0b 0.7 ± 0.1a 0.3 ± 0.0b 0.01 ± 0.01a 0.01 ± 0.01b 0.2 ± 0.1a 0.1 ± 0.0b 
Total anthocyanins 12.8 ± 0.3a 5.0 ± 0.1b 7.2 ± 0.6a 2.5 ± 0.1b 3.8 ± 1.0a 1.3 ± 0.4b 2.2 ± 0.8a 0.8 ± 0.3b 
Ellagic acid pentoside 0.6 ± 0.1a 0.1 ± 0.0b 0.4 ± 0.1a 0.1 ± 0.0b 0.1 ± 0.0a 0.02 ± 0.00b 0.4 ± 0.1a 0.1 ± 0.0b 
Ellagic acid    20.0 ± 2.1a 11.1 ± 1.2b 7.1 ± 1.0a 5.3 ± 0.8a 5.8 ± 0.5a 4.2 ± 0.3b 2.9± 1.4a 2.6 ± 0.8a 








Sanguiin H-10 10.0 ± 2.7a 0.8 ± 0.2b 6.0 ± 0.2a 0.5 ± 0.0b 4.7 ± 0.6a 0.5 ± 0.1b 2.1 ± 0.8a 0.1 ± 0.1b 
Sanguiin H-6 35.1 ± 3.3a 3.3 ± 0.3b 15.3 ± 5.0a 1.5 ± 0.5b 9.4 ± 1.2a 0.9 ± 0.1b 1.2 ± 0.3a 0.1 ± 0.0b 
Lambertianin C 5.4 ± 0.7a 0.4 ± 0.1b 1.8 ± 0.5a 0.1 ± 0.0b 1.2 ± 0.7a 0.1 ± 0.1b n.d. n.d. 
Total ellagitannins 50.5 ± 6.7a 4.5 ± 0.6b 23.1 ± 5.7a 2.1 ± 0.5b 15.3 ± 2.5a 1.5 ± 0.3b 3.3 ± 1.1a 0.2 ± 0.1b 
Total (poly)phenols 83.9 ± 9.4a 20.7 ± 1.9b 37.8 ± 7.4a 10.0 ± 1.4b 25 ± 4a 7 ± 1b 8.8 ± 3.4a 3.7 ± 1.2b 
1Different letters denote significant different within the same subject (p<0.05).  Can this be made standard error rather than SD. Insufficient sample available for the analysis 











Table 2. Quantities of anthocyanins, ellagic acid derivatives and ellagitannins recovered in A) ileal fluids 
collected 0-8 h after raspberry consumption and in B) raspberry ileal fluid after 24 h fecal fermentation. 
Data expressed as µmol ± SEM (for A n = 11, for B n = 3). 
Compounds 
A-Recovery after small intestine B-Recovery after fecal fermentation 
µmol ± SEM % Intake µmol ± SEM % Intake 
Cyanidin-3-O-sophoroside 4.7 ± 0.8 21.4 1.5 ± 0.1 7.0 
Cyanidin-3-O-(2"-O-glucosyl)rutinoside 1.2 ± 0.3 28.6 0.37 ± 0.03 8.9 
Pelargonidin-3-O-sophoroside 0.06 ± 0.02 24.0 0.02 ± 0.001 6.7 
Cyanidin-3-O-glucoside 0.11 ± 0.04 1.2 0.03 ± 0.003 0.3 
Cyanidin-3-O-rutinoside 0.23 ± 0.06 10.5 0.07 ± 0.01 3.4 
Total anthocyanins 6.3 ± 1.2 16.5 2.0 ± 0.2 5.3 
         
Ellagic acid-O-pentoside 0.4 ± 0.1 33.3 0.06 ± 0.003 4.9 
Ellagic acid    8.4 ± 1.5 175 5.2 ± 0.3 109 
Total ellagic acid 8.8 ± 1.6 147 5.3 ± 0.3 88 
         
Sanguiin H-10 6.0 ± 1.3 14.0 0.47 ± 0.03 1.1 
Sanguiin H-6 18.7 ± 4.9 30.7 1.16 ± 0.12 1.9 
Lambertianin C 1.6 ± 0.9 8.0 0.11 ± 0.12 0.6 




















Table 3. Concentration of anthocyanins, ellagic acid derivatives, ellagitannins and low molecular weight phenolics recovered in 
ileal fluids collected 0-8 h after raspberry consumption and in raspberry ileal fluid after a 24 h fecal fermentation. Data expressed 
as µM ± SEM (n = 11)a 
Compounds 
Concentration in ileal fluid 
Concentration in ileal fluid after fecal 
fermentation 
µM ± SEM Range (µM) µM ± SEM Range (µM) 
Total anthocyanins 7.1 ± 0.9 3.0 - 10.2 2.4 ± 0.3* 1.0 - 4.0 
Total ellagic acids 9.7 ± 1.7 2.8 - 16.4 6.9 ± 1.0 2.6 - 10.7 
Total ellagitannins 23.6 ± 4.9 5.3 - 41.9 2.1 ± 0.4* 0.3 - 3.7 
3-(3′-Hydroxyphenyl)propanoic acid 9 ± 1 n.d. - 13.0 25 ± 9** n.d. - 84 
3-(Phenyl)propanoic acid 6 ± 3 0.7 - 33 28 ± 14* n.d. - 144 
4-Hydroxybenzoic acid 26 ± 9 n.d. - 87 21 ± 5 4 - 51 
Benzoic acid 76 ± 20 14 - 246 149 ± 28* 30 - 357 
Total phenolicsb 581 ± 171 55 - 1668 807 ± 187** 162 - 1962 
aData on all of the individual phenolics detected in the samples and listed in Table S5 
bThe mean value post-fermentation is statistically different compared with the mean value pre-fermentation. One-way ANOVA and 






















Figure 1. Total amount of phenolic acids and aromatic catabolites present in ileal fluid before 
(baseline) and after (+raspberry) raspberry consumption analysed before (0 h) and after (24 h) 
fecal fermentation. Data expressed as µmol ± SEM (n =11). Significance compared Baseline vs 
























Figure 2. The impact of fecal fermentation on the total amount of phenolic acid and aromatic 
catabolites in ileal fluid collected before (Baseline) and after the consumption of 300 g of 
raspberry puree (+Raspberry) by 12 subjects. Baseline and +Raspberry samples before fecal 
fermentation (0 h). Baseline and +Raspberry samples after 24 h fecal fermentation (24 h).  
Significance compared for each subject between pre- and post-berry intake using one-way 























consumption (A and B) and post-raspberry consumption (C and D) before (red) and after (green) 24 h of fecal fermentation. Score plots are Figures 













Figure 4. Effects on DNA damage of ileal fluid fermentates (IFFs). A) Baseline and 
+Raspberry ileal fluids after 0 hr fermentation and B) Baseline and +Raspberry ileal 
fluids after 24 h fermentation (at 20% ileal fluids (v/v) in growth media). After 24 h 
pre-incubation at 37 °C, CoN CCD 841 cells were challenged with 25 μmol/L H2O2. 
Data expressed as mean of three independent experiments ± SDM. Significance is 











Figure 5. Changes in (A) Nrf2, (B) NQO1, (C) HO-1 gene expression after incubation for 24 h with 
Baseline and +Raspberry ileal fluid fermented for 24 h (20% v/v). Gene expression in CCD841 cells 
is presented as mean of 3 independent experiments ±SDM and expressed as absolute fold change. 
Significance is compared to normalised untreated control using One-way ANOVA and Dunnett’s 










Figure 6 . Effects on DNA damage of four phenolic compounds. Components were tested after 
24 h pre-incubation at 37°C, CoN CCD 841 cells were challenged with 25 μM H2O2. Data 
expressed as mean of 3 independent experiments ± SDM. Benzoic acid, 4-hydroxybenzoic acid, 
3-(3’-hydroxyphenyl)propanoic acid, 3-(phenyl)propanoic acid, at 10, 50, or 100 µM. 
Significance is compared to baseline (i.e. Untreated Control) using One-way ANOVA and 

















Figure 7. Change in (A) Nrf2, (B) NQO1, (C) HO-1 gene expression after pre-incubation with 
four phenolic compounds. Benzoic acid (BA), 4-hydroxybenzoic acid (4HBA), 3-(3’-
hydroxyphenyl)propanoic acid (3’HPPA), and 3-(phenyl)propanoic acid (3PPA). Absolute fold 
change in expression is presented as mean of 3 independent experiments ±SDM on CCD 841 
CoN cells. Significance is compared to normalised untreated control using One-way ANOVA and 
Dunnett’s Multiple Comparisons test. * p<0.05, **p<0.01, ***p<0.001.  
Highlights 
•      Health effects of dietary (poly)phenols linked to interactions within the GI tract 
  
•      Ileostomy-based bioavailability studies allow effective interrogation of the GI tract 
  
•      Fecal fermentation of raspberry-enriched ileal fluid, increases phenolic content 
  
•      Raspberry ileal fluid fermentates & phenolic acids reduce DNA damage in 
colonocytes 
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Table S1. HPLC-HRMS characteristics of polyphenols presented in ileal fluid collected 0-8 h after 300 g of raspberry intake. 
Chromatographic conditions were as follows: reverse phase separation was carried out using a 100 x 2.1 mm i.d. 1.8 µm 
Zorbax SB C18 (Agilent) maintained at 40 °C and eluted at a flow rate of 0.2 mL/min with a 50 min gradient of 3-70% of 0.1% 
acidic methanol in 0.1% aqueous formic acid. 
Compound RT (min) Chemical formula  [m/z]+a MSI MI  levelc 
Cyanidin-3,5-O-diglucoside 18.1 C27H30O16 611.1606 2 
Cyanidin-3-O-sophoroside 18.9 C27H30O16 611.1606 2 
Cyanidin-3-O-(2"-O-glucosyl)rutinoside 19.9 C33H40O20 757.2185 2 
Pelargonidin-3-O-sophoroside 23.5 C27H30O15 595.1657 2 
Cyanidin-3-O-glucoside 24.2 C21H20O11 449.1078 1 
Cyanidin-3-O-(2"-O-xylosyl)rutinoside 25.2 C32H38O19 727.2080 2 
Cyanidin-3-O- rutinoside 27.1 C27H30O15 594.1579 2 
Pelargonidin-3-O-glucoside 28.9 C21H20O10 433.11292 1 
Ellagic acid-O-pentoside 34.6 C19H14O12 b 433.0401 2 
Ellagic acid 35.6 C14H6O8 b 300.9978 1 
Sanguiin H-10 18.9 C68H48O44b 1567.14347 2 
Sanguiin H-6 26.0 C82H54O52b 1869.1497 2 
Lambertianin C 29.2 C123H80O78 b 2803.2209 2 
a Chemical formula [m/z]+ indicated the protonated molecule [M-H]+ 
bChemical formula [m/z]- indicated the deprotonated molecule [M-H]- 
c Metabolite Standards Initiative metabolite identification (MSIMI) levels [1]. Reference compounds were available for 








Table S2. GC retention times and characteristic MS ions of trimethylsilyl derivatives of phenolic and aromatic acid catabolites in ileal 
fluid collected 0-8 h after 300 g of raspberry intake. Commercially available standard compounds were used for all the phenolic acids 
quantified. The GC conditions were previously described by Pereira-Caro et al. [2]. 
Phenolic catabolites Rt (min) Target ion (m/z) Qualifier ions (m/z) 
Benzoic acid 5.8 105 179, 135, 77 
Benzene-1,2-diol (catechol) 6.4 254 73, 239, 151 
3-(Phenyl)propionic acid 7.4 104 75, 222 
Benzene 1,2,3-triol (pyrogallol) 8.8 239 73, 342 
2-Hydroxy-3-(phenyl)propanoic acid  [3-(phenyl)lactic acid] 9.5 193 73, 147 
3′-Hydroxyphenylacetic acid 10.5 267 73, 193, 282 
4-Hydroxybenzoic acid 10.9 267 282, 223, 193, 73  
4′-Hydroxyphenylacetic acid 11.1 73 296, 281, 179, 164 
3-(3´-Hydroxyphenyl)propionic acid 13.3 205 192 ,310, 177, 73 
3-(4´-Hydroxyphenyl)propionic acid 14.3 179 192, 73, 310 
3,4-Dihydroxybenzoic acid 15.4 193 73, 370, 355 
3-(3´,4´-Dihydroxyphenyl)propionic acid 20.6 73 179, 267, 398, 383 
3-(3′-Hydroxy-4′-methoxyphenyl)propionic acid 18.3 340 209, 192, 179, 73 
2-Hydroxy-3-(4′-hydroxyphenyl)propanoic acid  [3-(4′-hydroxyphenyl)lactic 
acid] 18.9 179 73, 147, 308 
3′,4′-Dihydroxycinnamic acid [caffeic acid] 22.1 308 73, 323, 249 
4′-Hydroxycinnamic acid [coumaric acid] 19.8 219 73, 249, 293, 308 








Table S3. Sequences of the forward (F, 5’ -> 3’) and reverse (R, 3’ -> 5’) primers designed for the Nrf2, HO-1, NQO1, HPRT, β-actin 
genes. The amplicon length is expressed as base pairs (bp). 
Gene Full Name Primer sequence Amplicon Length (bp) 
Nrf2 Nuclear factor (erythroid derived 2)-like 2 F: AAACCAGTGGATCTGCCAAC 
R: GCAATGAAGACTGGGCTCTC 
190 
HO-1 Heme oxygenase 1 F: ATGACACCAAGGACCAGAGC 
R: GTGTAAGGACCCATCGGAGA 
153 
NQ01 NAD(P)H dehydrogenase, quinone 1 F: AGGACCCTTCCGGAGTAAGA 
R: AGGCTGCTTGGAGCAAAATA 
279 
HPRT Hypoxanthine phosphoribosyl transferase F: AGCTTGCGACCTTGACCAT 
R: GACCAGTCAACAGGGGACAT 
166 










Table S4. Quantities of anthocyanins, ellagic acid derivatives 
and ellagitannins present in 300 g of a raspberry smoothy.  
Data expressed as µmol ± SDM (n=3). 
Compound µmol/300 g ± SDM 
Cyanidin-3,5-O-diglucoside 0.6 ± 0.1 
Cyanidin-3-O-sophoroside 22 ± 1 
Cyanidin-3-O-(2"-O-glucosyl)rutinoside 4.2 ± 0.3 
Pelargonidin-3-O-sophoroside 0.3 ± 0.0 
Cyanidin-3-O-glucoside 9 ± 1 
Cyanidin-3-O-(2"-O-xylosyl)rutinoside 0.3 ± 0.1 
Cyanidin-3-O-rutinoside 2.2 
Pelargonidin-3-O-glucoside 0.1 ± 0.1 




1.2 ± 0.1 
Ellagic acid 4.8 ± 0.1 




43 ± 3 
Sanguiin H-6 61 ± 3 
Lambertianin C 20 ± 2 









Table S5. The quantities of phenolic acids and aromatic catabolites present in ileal fluid from subjects ,who consumed 300 g of raspberry, before (0 
h) and after (24 h) fermentation with a human fecal sample. Data expressed as mean values in µmol ± SDM (n=3).   
 S1-0 h S1-24 h S2-0 h S2-24 h S3-0 h S3-24 h S4-0 h S4-24 h S5-0 h S5-24 h S6-0 h S6-24 h 
Cinnamic acid derivatives              
4′-Hydroxycinnamic acid  n.d. 2.1 ± 0.1 3.1 ± 0.7 n.d. 1.2 ± 0.3 0.6 ± 0.1 n.d. n.d. n.d. n.d. n.d. n.d. 
3´,4´-Dihydroxycinnamic acid n.d. 40 ± 5 25 ± 6 n.d. 2.1 ± 0.3 n.d. n.d. n.d. n.d. n.d. n.d. n.d. 
3’-Hydroxy-4’-methoxycinnamic acid n.d. n.d. n.d. n.d. 1.3 ± 0.2 n.d. n.d. n.d. n.d. n.d. n.d. n.d. 
Phenylpropanoic acid derivatives             
3-(3′-Hydroxyphenyl)propanoic acid n.d. n.d. n.d. n.d. 2.4 ± 0.3 4.1 ± 0.6 1.7 ± 0.2 2.1 ± 0.8 8 ± 1 7.2 ± 0.2 n.d. n.d. 
3-(4′-Hydroxyphenyl)propanoic acid n.d. 2.2 ± 0.8 0.2 ± 0.1 0.2 ± 0.1 n.d. n.d. n.d. 2.6 ± 0.2 n.d. n.d. n.d. n.d. 
3-(3′,4′-Dihydroxyphenyl)propanoic acid  n.d. n.d. n.d. n.d. n.d. n.d. 1.0 ± 0.2 n.d. n.d. n.d. 7.6 ± 0.5 n.d. 
3-(4′-Hydroxy-3′-methoxyphenyl)propanoic acid n.d. 11 ± 1 9 ± 2 n.d. n.d. n.d. n.d. n.d. n.d. n.d. 13 ± 2 4.0 ± 0.6 
3-(Phenyl)propanoic acid n.d. 4.4 ± 0.6 7 ± 1 1.0 ± 0.7 1.5 ± 0.2 1.2 ± 0.2 0.8 ± 0.2 3.1 ± 1.7 1.6 ± 0.4 1.1 ± 0.1 0.8 ± 0.3 2.9 ± 0.7 
2-Hydroxy-3-(4′-hydroxyphenyl)propanoic acid n.d. n.d. n.d. n.d. 0.3 ± 0.1 n.d. 1.2 ± 0.2 n.d. 5.3 ± 0.2 n.d. 1.7 ± 0.7 n.d. 
2-Hydroxy-3-(phenyl)propanoic acid 3.1 ± 0.3 3.6 ± 0.6 1.3 ± 0.8 2 ± 1 5 ± 1 0.4 ± 0.1 3.9 ± 1.0 n.d. n.d. n.d. 4.5 ± 0.3 13 ± 8 
Phenylacetic acid derivatives             
4′-Hydroxyphenylacetic acid  90 ± 12 104 ± 16 40 ± 8 4 ± 1 1.0 ± 0.2 1.3 ± 0.2 3.1 ± 0.3 n.d. 57 ± 2 3.2 ± 0.2 2.4 ± 0.4 21 ± 3 
3′-Hydroxyphenylacetic acid 40 ± 5 53 ± 6 15 ± 4 1.8 ± 0.3 0.3 ± 0.2 1.2 ± 0.2 n.d. n.d. n.d. n.d. n.d. n.d. 
Benzoic acids             
3,4-Dihydroxybenzoic acid n.d. 16 ± 1 6.7 ± 0.2 2.1 ± 0.3 n.d. n.d. n.d. 0.8 ± 0.4 n.d. n.d. n.d. 16 ± 2 
4-Hydroxybenzoic acid 24 ± 7 9.2 ± 5 6 ± 2 7.2 ± 0.9 0.4 ± 0.1 10 ± 1 4 ± 1 8.1 ± 0.7 n.d. n.d. 12 ± 3 14 ± 3 
Benzoic acid 56 ± 1 98 ± 10 16 ± 6 18 ± 1 31 ± 1 18 ± 1 24 ± 2 22 ± 2 18 ± 1 13 ± 4 12 ± 2 34 ±11 
Benzenetriols             
Benzene-1,2-diol (catechol) 474 ± 58 718 ± 7 522 ± 61 905 ± 23 44 ± 1 102 ± 8 151 ± 3 384 ± 16 249 ± 82 61 ± 2 50 ± 5 445 ± 45 
Benzene-1,2,3-triol (pyrogallol) 3.0 ± 0.3 3.0 ± 0.4 1.3 ± 0.3 3.7 ± 0.3 1.0 ± 0.2 0.8 ± 0.2 1.2 ± 0.9 0.5 ± 0.2 4.2 ± 0.7 2 ± 1 n.d. n.d. 
Total 690 ± 84 1064 ± 59 653 ± 92 945 ± 29 91 ± 5 140 ± 12 192 ± 9 423 ± 22 343 ± 87 87 ± 7 104 ± 14 550 ± 73 
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Table S5. Continued 
 S8-0 h S8-24 h S9-0 h S9-24 h S10-0 h S10-24 h S11-0 h S11-24 h S12-0 h S12-24 h 
Cinnamic acid derivatives              
4′-Hydroxycinnamic acid  0.4 ± 0.1 n.d. n.d. n.d. n.d. n.d. n.d. 8.9 ± 0.3 n.d. n.d. 
3´,4´-Dihydroxycinnamic acid n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 
3’-Hydroxy-4’-methoxycinnamic acid n.d. n.d. n.d. n.d. n.d. 2.3 ± 0.8 n.d. 9.5 ± 0.6 6.5 ± 0.4 n.d. 
Phenylpropanoic acid derivatives       
 
   
3-(3′-Hydroxyphenyl)propanoic acid 1.1 ± 0.2 1.9 ± 0.6 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 
3-(4′-Hydroxyphenyl)propanoic acid n.d. n.d. n.d. n.d. 2.8 ± 0.5 n.d. n.d. 0.2 ± 0.1 n.d. n.d. 
3-(3′,4′-Dihydroxyphenyl)propanoic acid  1.3 ± 0.2 n.d. n.d. 0.7 ± 0.2 n.d. 0.1 ± 0.1 n.d. 17 ± 1 n.d. n.d. 
3-(4′-Hydroxy-3′-methoxyphenyl)propanoic acid n.d. n.d. n.d. n.d. n.d. 2.7 ± 0.2 6 ± 1 13 ± 2 n.d. 2.4 ± 0.2 
3-(Phenyl)propanoic acid 0.3 ± 0.1 1.1 ± 0.4 0.3 ± 0.1 0.1 ± 0.1 3.8 ± 0.9 0.5 ± 0.3 2.7 ± 0.7 19 ± 1 6 ± 1 0.1 ± 0.1 
2-Hydroxy-3-(4′-hydroxyphenyl)propanoic acid 0.4 ± 0.1 n.d. n.d. n.d. n.d. n.d. 3.1 ± 0.2 n.d. 1.2 ± 0.3 n.d. 
2-Hydroxy-3-(phenyl)propanoic acid 2.3 ± 0.5 n.d. 1.2 ± 0.2 n.d. 1.8 ± 0.6 n.d. 2.7 ± 0.1 11 ± 1 0.4 ± 0.1 n.d. 
Phenylacetic acid derivatives           
4′-Hydroxyphenylacetic acid  2.8 ± 0.5 n.d. n.d. n.d. 26 ± 4 51 ± 10 8.5 ± 0.3 15 ± 1 7 ± 1 0.3 ± 0.1 
3′-Hydroxyphenylacetic acid n.d. n.d. n.d. n.d. n.d. 26 ± 6 n.d. n.d. n.d. n.d. 
Benzoic acids           
3,4-Dihydroxybenzoic acid n.d. 3.9 ± 0.8 n.d. 0.8 ± 0.2 n.d. 21 ± 7 n.d. 33 ± 1 n.d. 6.2 ± 0.6 
4-Hydroxybenzoic acid n.d. n.d. n.d. 3.8 ± 0.4 0.5 ± 0.1 1.6 ± 0.7 n.d. 26 ± 3 3 ± 1 n.d. 
Benzoic acid 36 ± 13 19 ± 12 4.7 ± 0.3 37 ± 2 30 ± 3 132 ± 5 44 ± 6 12 ± 6 18 ± 2 24 ± 7 
Benzenetriols           
Benzene-1,2-diol (catechol) 12 ± 5 11 ± 3.6 69 ± 11 84 ± 10 111 ± 14 368 ± 48 34 ± 2 120 ± 16 23 ± 1 140 ± 5 
Benzene-1,2,3-triol (pyrogallol) 1.6 ± 0.9 2.7 ± 0.7 2.7 ± 1.8 0.1 ± 0.1 0.8 ± 0.2 1.5 ± 0.7 0.4 ± 0.3 0.4 ± 1.8 0.1 ± 0.1 0.2 ± 0.1 





Table S6. A summary of the impact of fecal fermentation on the concentration of individual phenolic acids and aromatic catabolites 
present in ileal fluid from 11 subjects who consumed 300 g of raspberries before (0 h) and after (24 h) fermentation with human 
fecal samples. Data expressed as µM ± SEM (n=3).  The mean value post-fermentation is statistically different compared with the 







Mean ± SEM 
24 h 
Mean ± SEM 
Cinnamic acid derivatives     
4′-Hydroxycinnamic acid  n.d. -14.6 n.d. - 4 1.8 ± 0.4 0.6 ± 0.1* 
3´,4´-Dihydroxycinnamic acid n.d. - 51 n.d - 12 8.1 ± 1.7 1.1 ± 0.3* 
3’-Hydroxy-4’-methoxycinnamic acid n.d. – 17 n.d. - 13 1.8 ± 0.5 1.8 ± 0.4 
Phenylpropanoic acid derivatives     
3-(3′-Hydroxyphenyl)propanoic acid n.d. - 16 n.d. – 84 3.8 ± 0.5 18.5 ± 2.7* 
3-(4′-Hydroxyphenyl)propanoic acid n.d. - 51 n.d. - 26 6.1 ± 1.4 7.4 ± 0.9 
3-(3′,4′-Dihydroxyphenyl)propanoic acid  n.d. - 27 n.d. - 6 4.0 ± 0.7 0.8 ± 0.2* 
3-(4′-Hydroxy-3′-methoxyphenyl)propanoic acid n.d. – 38 n.d.- 18.4 4.2 ± 1.0 3.4 ± 0.6 
3-(Phenyl)propanoic acid n.d. - 33 n.d.- 144 6.0 ± 0.9 20 ± 4* 
2-Hydroxy-3-(4′-hydroxyphenyl)propanoic acid n.d.  n.d.-39 n.d. 10 ± 1* 
2-Hydroxy-3-(phenyl)propanoic acid n.d. - 24 n.d. - 137 5.7 ± 0.8 26 ± 3* 
Phenylacetic acid derivatives     
4′-Hydroxyphenylacetic acid  n.d. - 191 n.d. - 43 33 ± 5 8 ± 1* 
3′-Hydroxyphenylacetic acid n.d. - 86 n.d. - 12 11.0 ± 2.4 2.1 ± 0.4* 
Benzoic acids     
3,4-Dihydroxybenzoic acid n.d. - 33 n.d. - 6 12 ± 1 1.7 ± 0.2* 
4-Hydroxybenzoic acid n.d. - 87 3.6 - 51 19 ± 3  21 ± 2 
Benzoic acid 14 - 246 30 - 357 76 ± 7 149 ± 8* 
Benzenetriols     
Benzene-1,2-diol (catechol) 3.6 - 1564 n.d. - 1600 386 ± 60 533 ± 145* 
Benzene-1,2,3-triol (pyrogallol) n.d. - 10 n.d. - 8 3.7 ± 1.0 3.1 ± 0.2 
Total phenolics 54 - 1661 162 - 1962 581 ± 51 807± 56* 
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